SCHEMBL5143789

SCHEMBL5143789

Oc1cccc(Oc2cccc(Oc3cccc(O)c3)c2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.55
ALDH1A1 P00352 3/20 0.55
LMNA P02545 2/20 0.55
CA12 O43570 2/20 0.55
CA2 P00918 2/20 0.55
CA9 Q16790 2/20 0.55
CA14 Q9ULX7 2/20 0.55
CA5A P35218 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CA5B Q9Y2D0 1/20 0.55
MEN1 O00255 1/20 0.50
MITF O75030 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
GFER P55789 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NLRP1 Q9C000 1/20 0.50
NOD2 Q9HC29 1/20 0.50
LTA4H P09960 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3182473 1.00 CYP3A4 (0.55) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL29719326 1.00 CYP3A4 (0.55) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL813557 0.97 CYP3A4 (0.58) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL30358272 0.97 CYP3A4 (0.58) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL13899983 0.95 MEN1 (0.58) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL1174127 0.93 LTA4H (0.60) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL11817541 0.93 LTA4H (0.60) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL8076305 0.92 LTA4H (0.58) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL5027612 0.92 LTA4H (0.58) CYP3A4ALDH1A1LMNACA12CA2
SCHEMBL29458645 0.92 LTA4H (0.58) CYP3A4ALDH1A1LMNACA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-15 US disclosed
US-20230312812-A1 EPOXY RESIN THE BOEING COMPANY 2023-10-05 US disclosed
US-20230312812-A1 EPOXY RESIN THE BOEING COMPANY 2023-10-05 US disclosed
US-20230312812-A1 EPOXY RESIN THE BOEING COMPANY 2023-10-05 US disclosed
US-11718707-B2 Epoxy resin THE BOEING COMPANY (US) 2023-08-08 US disclosed
US-11718707-B2 Epoxy resin THE BOEING COMPANY (US) 2023-08-08 US disclosed
US-11718707-B2 Epoxy resin THE BOEING COMPANY (US) 2023-08-08 US disclosed
EP-4148047-A1 EPOXY RESIN The Boeing Company (US) 2023-03-15 EP disclosed
US-20210355269-A1 EPOXY RESIN COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2021-11-18 US disclosed
US-20210355269-A1 EPOXY RESIN COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2021-11-18 US disclosed
US-20190248953-A1 EPOXY RESIN THE BOEING COMPANY 2019-08-15 US disclosed
US-20190248953-A1 EPOXY RESIN THE BOEING COMPANY 2019-08-15 US disclosed
EP-3487904-A1 EPOXY RESIN The Boeing Company (US) 2019-05-29 EP disclosed
CN-109642018-A Epoxy resin 波音公司 2019-04-16 CN disclosed
WO-2018018070-A1 EPOXY RESIN THE BOEING COMPANY (US) 2018-02-01 WO disclosed
WO-2018018070-A1 EPOXY RESIN THE BOEING COMPANY (US) 2018-02-01 WO disclosed
CN-102597153-B Adhesive composition, circuit connecting structure, semiconductor device HITACHI CHEMICAL CO LTD 2014-07-30 CN disclosed
WO-2007102766-A1 PROCESS FOR PRODUCTION OF A BIS-PHTHALONITRILE MONOMER PERSTORP SPECIALTY CHEMICALS AB (SE) 2007-09-13 WO disclosed
WO-2007102766-A1 PROCESS FOR PRODUCTION OF A BIS-PHTHALONITRILE MONOMER PERSTORP SPECIALTY CHEMICALS AB (SE) 2007-09-13 WO disclosed
US-5578697-A DIELECTRIC POLYMERS FOR ELECTRONICS KABUSHIKI KAISHA TOSHIBA (JP) 1996-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718707-B2 Epoxy resin EPHX2, EPHX1, CBR1 CYP3A4 974/4885ALDH1A1 636/4885LMNA 954/4885
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TERT, TERB1, MCM5 CYP3A4 1827/4885ALDH1A1 1603/4885LMNA 988/4885
US-20210355269-A1 EPOXY RESIN EPHX2, EPHX1, CBR1 CYP3A4 974/4885ALDH1A1 636/4885LMNA 954/4885
US-20190248953-A1 EPOXY RESIN EPHX2, EPHX1, CBR1 CYP3A4 974/4885ALDH1A1 636/4885LMNA 954/4885
US-20230312812-A1 EPOXY RESIN EPHX2, EPHX1, CBR1 CYP3A4 974/4885ALDH1A1 636/4885LMNA 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.